United States
Germany
Japan
United Kingdom
China
eNOS (NOS3) rabbit polyclonal antibody, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Human, Mouse, Rat |
Products
eNOS (NOS3) pThr494 rabbit polyclonal antibody, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Human, Mouse, Rat |
eNOS (NOS3) pSer1177 mouse monoclonal antibody, clone 15E2, Purified
| Applications | ELISA, WB |
| Reactivities | Human |
eNOS (NOS3) pThr494 rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
eNOS (NOS3) pThr494 rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
NOS3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
NOS3 CRISPRa kit - CRISPR gene activation of human nitric oxide synthase 3
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Nos3 CRISPRa kit - CRISPR gene activation of mouse nitric oxide synthase 3, endothelial cell
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
qSTAR qPCR primer pairs against Mus musculus gene Nos3
Anti-eNOS (C-terminal region) Antibody
| Applications | ICC, IHC, WB |
| Reactivities | Human, Rat, Mouse |
Nos3 (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
Phospho-eNOS-S1177 Rabbit mAb
| Applications | WB |
| Reactivities | Human, Mouse |
Anti-eNOS (Ser-632), Phosphospecific Antibody
| Applications | WB |
| Reactivities | Human, Rat, Mouse |
qPCR primer pairs and template standards against Homo sapiens gene NOS3
| Application | Plasmid of exact quantity for transcript copy number calculation |
NOS3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
